Clinical Trial Update: Effect of Galactose on Permeblity Factor in Patients With FSGS and CKD Stage 5 [Phase 1]

View source ↗

Summary

A Phase 1 trial investigating the effect of galactose on a permeability factor in patients with Focal Segmental Glomerulosclerosis and Chronic Kidney Disease st…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease
• End-stage Renal Disease
• Focal Segmental Glomerulosclerosis

Drugs mentioned

• Galactose (galactose)

Snippet

Sponsor: Northwell Health | Conditions: Focal Segmental Glomerulosclerosis | Phase 1 | Status: WITHDRAWN